Literature DB >> 24782286

Efficacy and Safety of Sufentanil and Pethidine in Spinal Anesthesia for Painless Labor.

S Salarian1, M Fathi1, B Farzanegan1, B Bagheri2.   

Abstract

Saddle spinal is a reliable method for control of pain during labor. This method has rapid onset and causes complete sensory block without significant influence on motor neurons.Our goal was to compare the analgesic efficacy and side effects of pethidine and sufentanil via saddle spinal administration during labor.600 parturients requesting analgesia were randomly divided into 2 groups. First group was composed of 300 patients received 0.4 mg/kg pethidine and the second group was composed of 300 patients received 0.1 μg/kg sufentanil. Then, analgesia according to Visual Analogue Scale (VAS), itching, nausea, apnea and urinary retention were examined between 2 groups.VAS=3 was noted in both groups. Equal rate of apnea was seen in both groups. Patients received pethidine showed significantly a higher rate of nausea compared with sufentanil group (P<0.0001). Pruritus was significantly higher in patients received sufantanil (P<0.0001).Our findings suggest that saddle spinal by pethidine or sufentanil causes a considerable analgesia for labor. Proper management of the untoward effects of this method may introduce it as a safe and low-cost method for painless labor. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24782286     DOI: 10.1055/s-0034-1372610

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  2 in total

1.  Effect of preemptive intravenous oxycodone on low-dose bupivacaine spinal anesthesia with intrathecal sufentanil.

Authors:  Jinguo Wang; Lei Pang; Wei Han; Guohua Li; Na Wang
Journal:  Saudi Med J       Date:  2015-04       Impact factor: 1.484

2.  Randomized single-blind comparative study of the midazolam/pethidine combination and midazolam alone during bronchoscopy.

Authors:  Masahiro Katsurada; Motoko Tachihara; Naoko Katsurada; Naoya Takata; Hiroki Sato; Chihiro Mimura; Junya Yoshioka; Koichi Furukawa; Masako Yumura; Takehiro Otoshi; Yuichiro Yasuda; Tatsunori Kiriu; Daisuke Hazama; Tatsuya Nagano; Masatsugu Yamamoto; Yoshihiro Nishimura; Kazuyuki Kobayashi
Journal:  BMC Cancer       Date:  2022-05-12       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.